These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 28639592)

  • 61. [Lupus nephritis].
    Schreiber J; Eisenberger U; de Groot K
    Internist (Berl); 2019 May; 60(5):468-477. PubMed ID: 30840107
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Progress and perspectives in the treatment of systemic lupus erythematosus].
    Robak E; Sysa-Jedrzejowska A; Wozniacka A
    Przegl Lek; 2005; 62(9):894-9. PubMed ID: 16541725
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction and maintenance therapy in proliferative lupus nephritis.
    Ponticelli C; Glassock RJ; Moroni G
    J Nephrol; 2010; 23(1):9-16. PubMed ID: 20091481
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
    Dooley MA; Jayne D; Ginzler EM; Isenberg D; Olsen NJ; Wofsy D; Eitner F; Appel GB; Contreras G; Lisk L; Solomons N;
    N Engl J Med; 2011 Nov; 365(20):1886-95. PubMed ID: 22087680
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
    Li X; Ren H; Zhang Q; Zhang W; Wu X; Xu Y; Shen P; Chen N
    Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of lupus nephritis: practical issues in Asian countries.
    Yap DY; Chan TM
    Int J Rheum Dis; 2015 Feb; 18(2):138-45. PubMed ID: 24965809
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacological therapy of lupus nephritis.
    Fine DM
    JAMA; 2005 Jun; 293(24):3053-60. PubMed ID: 15972568
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
    Bertsias GK; Tektonidou M; Amoura Z; Aringer M; Bajema I; Berden JH; Boletis J; Cervera R; Dörner T; Doria A; Ferrario F; Floege J; Houssiau FA; Ioannidis JP; Isenberg DA; Kallenberg CG; Lightstone L; Marks SD; Martini A; Moroni G; Neumann I; Praga M; Schneider M; Starra A; Tesar V; Vasconcelos C; van Vollenhoven RF; Zakharova H; Haubitz M; Gordon C; Jayne D; Boumpas DT;
    Ann Rheum Dis; 2012 Nov; 71(11):1771-82. PubMed ID: 22851469
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An Update on the Diagnosis and Management of Lupus Nephritis.
    Kostopoulou M; Adamichou C; Bertsias G
    Curr Rheumatol Rep; 2020 Jun; 22(7):30. PubMed ID: 32500443
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.
    Mak A; Mok CC
    Lupus; 2005; 14(10):856-8. PubMed ID: 16302683
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Current and Emerging Therapy on Lupus Nephritis.
    Bawazier LA
    Acta Med Indones; 2017 Oct; 49(4):369-377. PubMed ID: 29348390
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recent Advances in Treatment Strategies for Lupus Nephritis.
    Karasawa K; Uchida K; Takabe T; Moriyama T; Nitta K
    Contrib Nephrol; 2018; 195():42-50. PubMed ID: 29734149
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mycophenolate mofetil in lupus nephritis.
    Ginzler EM; Aranow C
    Lupus; 2005; 14(1):59-64. PubMed ID: 15732290
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mycophenolate mofetil: a magic bullet for lupus?
    McCune WJ; Riskalla MM
    J Rheumatol; 2005 Jun; 32(6):967-70. PubMed ID: 15940751
    [No Abstract]   [Full Text] [Related]  

  • 75. Human clinical trials in lupus nephritis.
    Dooley MA; Falk RJ
    Semin Nephrol; 2007 Jan; 27(1):115-27. PubMed ID: 17336693
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study.
    Abe Y; Tada K; Yamaji K; Tamura N
    Biomed Res Int; 2021; 2021():8630596. PubMed ID: 33564682
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effectiveness of renoprotective approaches for persistent proteinuria in lupus nephritis: more than just immunosuppression.
    Castro M; Ugolini-Lopes M; Borba EF; Bonfá E; Seguro LPC
    Lupus; 2018 Dec; 27(14):2215-2219. PubMed ID: 30394834
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel therapies of lupus nephritis.
    Schieppati A; Remuzzi G
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):156-61. PubMed ID: 18277148
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Renal flare prediction and prognosis in lupus nephritis Hispanic patients.
    Mejía-Vilet JM; Córdova-Sánchez BM; Arreola-Guerra JM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R
    Lupus; 2016 Mar; 25(3):315-24. PubMed ID: 26405028
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis.
    Killen JP
    N Engl J Med; 2006 Feb; 354(7):764-5; author reply 764-5. PubMed ID: 16482673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.